Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment - Albumin excretion

70Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A single antibody radioimmunoassay has been used to measure albumin excretion in 3 groups of female Wistar rats. Two groups had Streptozotocin diabetes and were treated daily with insulin for 6 months. In one of the diabetic groups good glycaemic control was attempted and throughout the 6 months plasma glucose levels were fairly close to normal (92 ± 33 mg/100 ml at 2300 h and 186 ± 9 mg/100 ml at 0800 h). In the other diabetic group poor control was intended and the group had consistent high plasma glucose levels (576 ± 89 mg/100 ml and 460 ± 43 mg/100 ml). The third group was a non-diabetic control group. - Albumin excretion was measured on two occasions: before the induction of diabetes and after 6 months of diabetes. The geometric mean albumin excretion increased from 0.38 to 2.56 mg/24 h in the 18 non-diabetic controls. In the 20 diabetic rats in "good" control the geometric mean albumin excretion increased from 0.37 to 1.58 mg/ 24 h (NS compared with controls) and in the group of 22 rats in poor control albumin excretion increased from 0.35 to 6.54 mg/24 h. - The increase in albumin excretion in rats in poor control differed significantly both from that of the non-diabetic controls (2p = 0.023) and from that of the "well-controlled" diabetic rats (2p = 0.00011). © 1980 Springer-Verlag.

Cite

CITATION STYLE

APA

Rasch, R. (1980). Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment - Albumin excretion. Diabetologia, 18(5), 413–416. https://doi.org/10.1007/BF00276823

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free